LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study

INTRODUCTION: Grades 2 and 3 gliomas (G2/3 gliomas), when combined, are the second largest group of malignant brain tumours in adults. The outcomes for G2/3 gliomas at progression approach the dismal outcomes for glioblastoma (GBM), yet there is a paucity of trials for Australian patients with relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Benjamin Y, Sim, Hao-Wen, Nowak, Anna K, Yip, Sonia, Barnes, Elizabeth H, Day, Bryan W, Buckland, Michael E, Verhaak, Roel, Johns, Terrance, Robinson, Cleo, Thomas, Marc A, Giardina, Tindaro, Lwin, Zarnie, Scott, Andrew M, Parkinson, Jonathon, Jeffree, Rosalind, Lourenco, Richard de Abreu, Hovey, Elizabeth J, Cher, Lawrence M, Kichendasse, Ganessan, Khasraw, Mustafa, Hall, Merryn, Tu, Emily, Amanuel, Benhur, Koh, Eng-Siew, Gan, Hui K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719186/
https://www.ncbi.nlm.nih.gov/pubmed/37185327
http://dx.doi.org/10.1136/bmjopen-2021-054075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719186/
https://www.ncbi.nlm.nih.gov/pubmed/37185327
http://dx.doi.org/10.1136/bmjopen-2021-054075

Ejemplares similares